60 Degrees Pharmaceuticals Inc. (SXTP) Live Share Price, Invest From India

60 Degrees Pharmaceuticals Inc. Stock Performance

as on August 8, 2026 at 2:15 pm IST

Day's Low
Day's High
$1.08
Day's Price Range
$1.19
$1.12
3.57%
Downside
6.25%
Upside
52 Week's Low
52 Week's High
$1.05
52-Week Price Range
$8.62
$1.12
6.25%
Downside
669.64%
Upside

60 Degrees Pharmaceuticals Inc. share price movements today

Previous Close: $1.15
Open: $1.14
Volume: 513.6K
Day's Low - High: $1.08 - $1.19
52 Week Low - High: $1.05 - $8.62

60 Degrees Pharmaceuticals Inc. Historical Returns

1 Month Return: -26.28 %
3 Month Return: -25.32 %
1 Year Return: -79.32 %
3 Year Return: -99.69 %
5 Year Return: 0 %

60 Degrees Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check 60 Degrees Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.2M

EPS (TTM)

-3.45

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-172.82%

60 Degrees Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of 60 Degrees Pharmaceuticals Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
60 Degrees Pharmaceuticals Inc.	BUY	$3.2M	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$41.9B	624.31%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$122.9B	141.53%	27.85	35.00%	NA
Regeneron Pharmaceuticals Inc.	BUY	$79.1B	25.76%	18.83	27.87%	0.48%

Stock Returns calculator for 60 Degrees Pharmaceuticals Inc. Stock including INR - Dollar returns

The 60 Degrees Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

60 Degrees Pharmaceuticals Inc. investment value today

Current value as on today

₹21,877

Returns

-₹78,123

(-78.12%)

Returns from 60 Degrees Pharmaceuticals Inc. Stock

-₹79,856 (-79.86%)

Dollar Impact

₹1,733 (+1.73%)

Analyst Recommendation on 60 Degrees Pharmaceuticals Inc. Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for 60 Degrees Pharmaceuticals Inc.. Average target price of $3.7

60 Degrees Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on 60 Degrees Pharmaceuticals Inc..

What analysts predicted

69.73%UPSIDE

Target Price

$3.7

Current Price

$1.12

Analyzed by

8 Analysts

Target

$3.70

60 Degrees Pharmaceuticals Inc. target price $3.7, a slight upside of 69.73% compared to current price of $1.12. According to 8 analysts rating.

Indian Investors' Interest in 60 Degrees Pharmaceuticals Inc. Stock

Search interest for 60 Degrees Pharmaceuticals Inc. Stock has increased by 56% in the last 30 days, reflecting an upward trend in search activity.

Time period: July 10, 2026 to August 9, 2026

Change:56% versus previous 30 day period

60 Degrees Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-1	0	-4	-2	-2	-1	-1	-2	-1	-2
Net Profit Margin	-4584.98%	407.36%	-3338.95%	-1596.38%	-783.65%	-1147.37%	-1717.72%	-529.48%	-474.98%	-1289.49%

60 Degrees Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	2	1	0	0	0	1
Gross Profit	1	0	0	0	0	0
Operating Income	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-
Net Income	-3	-4	-6	-3	-7	-7
Net Profit Margin	-139.08%	-366.42%	-2769.49%	-1485.06%	-1308.01%	-732.82%

Global Institutional Holdings in 60 Degrees Pharmaceuticals Inc.

Funds	Holdings
Goss Wealth Management LLC	0%
Kathmere Capital Management, LLC	5.44%
Advisor Group Holdings, Inc.	0%
Citigroup Inc	0%
UBS Group AG	1.18%

See all

Insights on 60 Degrees Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 465.2% return, outperforming this stock by 544.5%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 567.8% return, outperforming this stock by 667.5%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 437.60K → 162.09K (in $), with an average decrease of 38.6% per quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, SXTP stock has moved down by -26.3%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -1.44M → -2.09M (in $), with an average decrease of 45.1% per quarter

About 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue fever. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Washington, District Of Columbia.

Organisation	60 Degrees Pharmaceuticals Inc.
Headquarters	1025 Connecticut Avenue NW, Washington, DC, United States, 20036
Industry	Biotechnology
CEO	Dr. Geoffrey Stuart Dow Ph.D.
E-voting on shares	Click here to vote

Key Management of 60 Degrees Pharmaceuticals Inc.

Name	Title
Dr. Bryan Smith	Chief Medical Officer
Dr. Geoffrey Stuart Dow Ph.D.	Chairman, CEO & President
Mr. Tyrone Miller	CFO & Treasurer
Ms. Kristen Landon	Chief Commercial Officer

FAQs

What is 60 Degrees Pharmaceuticals Inc. share price today?

60 Degrees Pharmaceuticals Inc. share price today is $1.12 as on August 8, 2026 at 8:45 am IST at the close of the market. 60 Degrees Pharmaceuticals Inc. share today touched a day high of $1.19 and a low of $1.08.

What is the 52 week high and 52 week low for 60 Degrees Pharmaceuticals Inc. share?

60 Degrees Pharmaceuticals Inc. share touched a 52 week high of $8.62 on January 1, 1970 and a 52 week low of $1.05 on January 1, 1970. 60 Degrees Pharmaceuticals Inc. stock price today i.e. August 8, 2026 at 8:45 am IST is closed at $1.12,which is 87.01% down from its 52 week high and 6.67% up from its 52 week low.

What is 60 Degrees Pharmaceuticals Inc.'s market capitalisation today?

60 Degrees Pharmaceuticals Inc. market capitalisation is $0.00T as on August 8, 2026 at 8:45 am IST.

How to invest in 60 Degrees Pharmaceuticals Inc. Stock (SXTP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for 60 Degrees Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in 60 Degrees Pharmaceuticals Inc. Shares that will get you 1.3393 shares as per 60 Degrees Pharmaceuticals Inc. share price of $1.12 per share as on August 8, 2026 at 8:45 am IST.

What is the minimum amount required to buy 60 Degrees Pharmaceuticals Inc. Stock (SXTP) from India?

Indian investors can start investing in 60 Degrees Pharmaceuticals Inc. (SXTP) shares with as little as ₹95.2 or $1 (as of August 9, 2026 at 9:59 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in 60 Degrees Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on August 9, 2026 at 9:59 pm IST). Based on 60 Degrees Pharmaceuticals Inc. share’s latest price of $1.12 as on August 8, 2026 at 8:45 am IST, you will get 8.9286 shares of 60 Degrees Pharmaceuticals Inc.. Learn more about fractional shares .